170 related articles for article (PubMed ID: 31291971)
1. DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma.
Luo X; Li N; Zhao X; Liao C; Ye R; Cheng C; Xu Z; Quan J; Liu J; Cao Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):300. PubMed ID: 31291971
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of dehydrogenase/reductase member 2 (DHRS2) in the pathology of disease.
Li Z; Liu H; Bode A; Luo X
Eur J Pharmacol; 2021 May; 898():173972. PubMed ID: 33652058
[TBL] [Abstract][Full Text] [Related]
3. DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism.
Li Z; Tan Y; Li X; Quan J; Bode AM; Cao Y; Luo X
Cell Death Dis; 2022 Oct; 13(10):845. PubMed ID: 36192391
[TBL] [Abstract][Full Text] [Related]
4. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
[TBL] [Abstract][Full Text] [Related]
5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
6. Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration.
Liao C; Li M; Li X; Li N; Zhao X; Wang X; Song Y; Quan J; Cheng C; Liu J; Bode AM; Cao Y; Luo X
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158540. PubMed ID: 31678511
[TBL] [Abstract][Full Text] [Related]
7. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
8. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
9. Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer.
Han Y; Wang Z; Sun S; Zhang Z; Liu J; Jin X; Wu P; Ji T; Ding W; Wang B; Gao Q
Epigenetics; 2020; 15(1-2):122-133. PubMed ID: 31423895
[TBL] [Abstract][Full Text] [Related]
10. BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
Liu Y; Zhao R; Wei Y; Li M; Wang H; Niu W; Zhou Y; Qiu Y; Fan S; Zhan Y; Xiong W; Zhou Y; Li X; Li Z; Li G; Zhou M
J Exp Clin Cancer Res; 2018 Mar; 37(1):64. PubMed ID: 29559001
[TBL] [Abstract][Full Text] [Related]
11. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
12. DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.
Zhou Y; Wang L; Ban X; Zeng T; Zhu Y; Li M; Guan XY; Li Y
Oncogene; 2018 Feb; 37(8):1086-1094. PubMed ID: 29106393
[TBL] [Abstract][Full Text] [Related]
13. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA NPCCAT1 promotes nasopharyngeal carcinoma progression via upregulating YY1.
Su H; Liu L; Zhang Y; Wang J; Zhao Y
Biochimie; 2019 Feb; 157():184-194. PubMed ID: 30481541
[TBL] [Abstract][Full Text] [Related]
15. Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways.
Kong L; Li X; Wang H; He G; Tang A
Biomed Pharmacother; 2018 Oct; 106():342-348. PubMed ID: 29966979
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of DHRS2 by SUV420H2 inhibits cell apoptosis in renal cell carcinoma.
Ryu TY; Lee J; Kang Y; Son MY; Kim DS; Lee YS; Kim MY; Cho HS
Biochem Biophys Res Commun; 2023 Jun; 663():41-46. PubMed ID: 37119764
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
Yin W; Shi L; Mao Y
J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors.
Nettersheim D; Berger D; Jostes S; Skowron M; Schorle H
J Cell Mol Med; 2019 Jan; 23(1):670-679. PubMed ID: 30460772
[TBL] [Abstract][Full Text] [Related]
19. CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells.
Ge Y; Long Y; Xiao S; Liang L; He Z; Yue C; Wei X; Zhou Y
Int J Oncol; 2019 Feb; 54(2):585-599. PubMed ID: 30535454
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ZFAS1 promotes nasopharyngeal carcinoma through activation of Wnt/β-catenin pathway.
Chen X; Li J; Li CL; Lu X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3423-3429. PubMed ID: 29917194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
